デフォルト表紙
市場調査レポート
商品コード
1618285

移動式心臓モニタリングデバイスの世界市場の評価:デバイスタイプ別、エンドユーザー別、地域別、機会、予測(2018年~2032年)

Ambulatory Cardiac Monitoring Devices Market Assessment, By Device Type, By End-user, By Region, Opportunities and Forecast, 2018-2032F


出版日
ページ情報
英文 243 Pages
納期
3~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
移動式心臓モニタリングデバイスの世界市場の評価:デバイスタイプ別、エンドユーザー別、地域別、機会、予測(2018年~2032年)
出版日: 2024年12月20日
発行: Market Xcel - Markets and Data
ページ情報: 英文 243 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の移動式心臓モニタリングデバイスの市場規模は、2023年の69億7,000万米ドルから2032年に148億米ドルに達すると予測され、予測期間の2025年~2032年にCAGRで9.88%の成長が見込まれます。市場成長を支えるさまざまな要因には、人々の心臓の健康に対する意識の高まり、適切なモニタリングデバイスを必要とする心臓病の罹患率の増加、技術の進歩、医療インフラとサービスへの投資の増加などがあります。さらに、外来患者の動向や遠隔医療サービスの増加が遠隔モニタリング技術の成長を促進しています。

移動式心臓モニターは、患者の心臓の活動を長期間にわたって記録します。これらのツールは、日常的な臨床心電図では特定できないような心疾患の診断と管理に極めて重要です。世界中での心血管疾患の急増により、モニタリングデバイスの使用が必要となっています。生活習慣には、食事、運動不足、喫煙、大気汚染への暴露などがあり、これらはこの動向に大きく寄与しています。American College of Cardiologyによると、CVDによる世界の死亡者数は1990年の約1,240万人から2022年に1,980万人に増加しています。疾患の有病率の増加と健康的なライフスタイルへの意識を高めるための政府の取り組みが、世界の移動式心臓モニタリングデバイス市場を牽引しています。

多国籍企業は、心臓モニタリング製品を強化するために戦略的買収を行っており、移動式心臓モニタリングデバイス市場の成長を促進しています。2024年5月、WearLinq, Inc.はAMI Cardiac Monitoring, LLCを買収しました。この買収と近年の670万米ドルの資金調達により、WearLinqは先進のeWave 6リードECGモニターへのアクセスを増やすことができます。さらに、リアルタイムのデータ伝送と遠隔患者管理により、遠隔医療も移動式心臓モニタリングデバイス市場を牽引しています。この統合により、患者のエンゲージメントが高まり、医療提供者はより適切でタイムリーな意思決定を行うことができます。時間の経過とともに、このようなデバイスはますます利用できるようになり、心血管治療と患者の転帰を改善する実りある機会を提供します。

当レポートでは、世界の移動式心臓モニタリングデバイス市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢などを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェアの分析と予測
    • デバイスタイプ別
    • エンドユーザー別
    • 地域別
    • 市場シェア分析:企業別(金額)(上位5社とその他 - 2024年)
  • 市場マップ分析(2024年)
    • デバイスタイプ別
    • エンドユーザー別
    • 地域別

第5章 北米の移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)

  • 市場規模の分析と予測
    • 金額
    • 数量
  • 市場シェアの分析と予測
    • デバイスタイプ別
    • エンドユーザー別
    • シェア:国別
  • 各国の市場の評価
    • 米国の移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)
    • カナダ
    • メキシコ

第6章 欧州の移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)

  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド

第7章 アジア太平洋の移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)

  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン

第8章 南米の移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)

  • ブラジル
  • アルゼンチン

第9章 中東・アフリカの移動式心臓モニタリングデバイス市場の見通し(2018年~2032年)

  • サウジアラビア
  • アラブ首長国連邦
  • 南アフリカ

第10章 需給分析

第11章 輸入と輸出の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

  • 市場促進要因
  • 市場の課題

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

  • 規制当局の承認

第19章 ケーススタディ

第20章 競合情勢

  • マーケットリーダー上位5社の競合マトリクス
  • 上位5社のSWOT分析
  • 主要企業上位10社の情勢
    • Medtronic plc
    • Boston Scientific Corporation
    • Koninklijke Philips N.V.
    • GE HealthCare Technologies Inc.
    • Medicomp Systems, Inc.
    • Biotronik SE & Co KG
    • iRhythm Technologies, Inc.
    • Hill-Rom Holdings, Inc.
    • Schiller AG
    • Nihon Kohden America, Inc.

第21章 戦略的推奨

第22章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. Global Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 3. Global Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 4. Global Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 5. Global Ambulatory Cardiac Monitoring Devices Market Share (%), By Region, 2018-2032F
  • Figure 6. North America Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 7. North America Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 8. North America Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 9. North America Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 10. North America Ambulatory Cardiac Monitoring Devices Market Share (%), By Country, 2018-2032F
  • Figure 11. United States Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 12. United States Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 13. United States Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 14. United States Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 15. Canada Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 16. Canada Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 17. Canada Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 18. Canada Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 19. Mexico Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 20. Mexico Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 21. Mexico Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 22. Mexico Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 23. Europe Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 24. Europe Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 25. Europe Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 26. Europe Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 27. Europe Ambulatory Cardiac Monitoring Devices Market Share (%), By Country, 2018-2032F
  • Figure 28. Germany Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 29. Germany Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 30. Germany Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 31. Germany Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 32. France Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 33. France Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 34. France Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 35. France Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 36. Italy Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 37. Italy Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 38. Italy Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 39. Italy Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 40. United Kingdom Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 41. United Kingdom Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 42. United Kingdom Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 43. United Kingdom Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 44. Russia Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 45. Russia Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 46. Russia Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 47. Russia Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 48. Netherlands Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 49. Netherlands Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 50. Netherlands Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 51. Netherlands Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 52. Spain Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 53. Spain Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 54. Spain Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 55. Spain Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 56. Turkey Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 57. Turkey Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 58. Turkey Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 59. Turkey Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 60. Poland Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 61. Poland Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 62. Poland Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 63. Poland Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 64. South America Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 65. South America Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 66. South America Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 67. South America Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 68. South America Ambulatory Cardiac Monitoring Devices Market Share (%), By Country, 2018-2032F
  • Figure 69. Brazil Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 70. Brazil Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 71. Brazil Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 72. Brazil Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 73. Argentina Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 74. Argentina Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 75. Argentina Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 76. Argentina Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 77. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 78. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 79. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 80. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 81. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market Share (%), By Country, 2018-2032F
  • Figure 82. India Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 83. India Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 84. India Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 85. India Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 86. China Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 87. China Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 88. China Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 89. China Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 90. Japan Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 91. Japan Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 92. Japan Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 93. Japan Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 94. Australia Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 95. Australia Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 96. Australia Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 97. Australia Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 98. Vietnam Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 99. Vietnam Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 100. Vietnam Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 101. Vietnam Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 102. South Korea Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 103. South Korea Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 104. South Korea Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 105. South Korea Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 106. Indonesia Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 107. Indonesia Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 108. Indonesia Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 109. Indonesia Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 110. Philippines Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 111. Philippines Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 112. Philippines Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 113. Philippines Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 114. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 115. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 116. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 117. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 118. Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Share (%), By Country, 2018-2032F
  • Figure 119. Saudi Arabia Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 120. Saudi Arabia Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 121. Saudi Arabia Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 122. Saudi Arabia Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 123. UAE Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 124. UAE Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 125. UAE Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 126. UAE Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 127. South Africa Ambulatory Cardiac Monitoring Devices Market, By Value, In USD Billion, 2018-2032F
  • Figure 128. South Africa Ambulatory Cardiac Monitoring Devices Market, By Volume, in Million Units, 2018-2032F
  • Figure 129. South Africa Ambulatory Cardiac Monitoring Devices Market Share (%), By Device Type, 2018-2032F
  • Figure 130. South Africa Ambulatory Cardiac Monitoring Devices Market Share (%), By End-user, 2018-2032F
  • Figure 131. By Device Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 132. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 133. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024
目次
Product Code: MX12435

Global ambulatory cardiac monitoring devices market is projected to witness a CAGR of 9.88% during the forecast period 2025-2032, growing from USD 6.97 billion in 2023 to USD 14.80 billion in 2032. Various factors supporting the market growth include rising awareness of cardiac health among individuals, increasing incidences of heart diseases, which demand suitable monitoring devices, technological advancements, and growing investments in healthcare infrastructure and services. Additionally, the outpatient trend and increased telehealth services promote the growth of remote monitoring technologies.

Ambulatory cardiac monitors record heart activity in a patient over a long period. These tools are crucial in diagnosing and managing cardiac conditions that would otherwise not be identified using routine clinical ECGs. The surge in cardiovascular diseases globally has necessitated the use of monitoring equipment. Lifestyle factors include diet, lack of physical activity, smoking, and exposure to air pollution, which have significantly contributed to this trend. According to the American College of Cardiology, the global deaths due to CVD have increased from around 12.4 million in 1990 to 19.8 million in 2022. The increasing prevalence of diseases and efforts from the government to raise awareness towards healthy lifestyles drive the global ambulatory cardiac monitoring devices market.

Multinational companies are making strategic acquisitions to enhance their cardiac monitoring products, driving growth in the ambulatory cardiac monitoring devices market. In May 2024, WearLinq, Inc. acquired AMI Cardiac Monitoring, LLC. This acquisition, combined with a recent funding round of USD 6.7 million, allows WearLinq to increase access to its advanced eWave 6-lead ECG monitor. Moreover, telehealth is also driving the market for ambulatory cardiac monitoring devices due to real-time data transmission and remote patient management. This integration boosts patient engagement and allows healthcare providers to make better, more timely decisions. With time, such devices will become increasingly available, offering fruitful opportunities for improved cardiovascular care and patient outcomes.

Growing Awareness About Cardiac Health Boosts Market Demand

Growing heart health awareness has led to a high demand for ambulatory cardiac monitoring devices. With greater public awareness of CVDs, people are becoming more proactive in seeking preventive measures and monitoring solutions. Also, organizations have increased efforts to educate the public about heart health, risk factors, and the significance of regular monitoring. All these have done much more to raise the visibility and demand for cardiac monitoring devices. On World Heart Day in September 2024, P. D. Hinduja Hospital and Medical Research Centre launched the campaign "Unmute Your Heart." This campaign highlighted the urgent need to prioritize heart health by adopting healthy lifestyle changes.

Similarly, in October 2024, Emcure Pharmaceuticals Ltd. launched a campaign called "ACE YOUR HEART," an awareness focus on cardiovascular health in India. In this campaign, they collaborated with more than 5,000 doctors nationwide to raise awareness about heart health. The company created the record-breaking largest heart structure to show its continued commitment to heart health. Such growing initiatives by organizations support market growth. As awareness of heart health increases, it is an ideal environment for the ambulatory cardiac monitoring devices market, offering scopes for innovation and greater adoption by consumers and healthcare providers alike.

Recent Advancements in Wearable Devices are Supporting Market Growth

The newest advances in ambulatory cardiac monitoring equipment are revolutionizing the scope of cardiac monitoring because they obtain and analyze long-term cardiac information to give a more precise diagnosis. Such advancements have made ambulatory monitoring devices popular for continuous heart monitoring, providing an affordable yet efficient way to monitor vulnerable patients from their homes. The integration and advancements in signal processing bring better accuracy and accessibility. They help in the early detection of critical physiological changes for timely medical alerts. Advances in wearable technology have made patients' health data more accessible, thus promoting proactive care for cardiovascular diseases. The more healthcare becomes aligned with wearables, the more its adoption rates should also rise. Changes like this can only lead to better patient outcomes and address the growing demand for effective cardiac monitoring solutions.

Companies also invest in digital healthcare and remote patient monitoring technologies that complement ambulatory cardiac devices. In May 2024, VivaLNK, Inc. launched a complete Mobile Cardiac Telemetry (MCT) and Holter monitoring solution that integrates remote patient monitoring (RPM) technology with advanced arrhythmia detection. This approach improves patient care, simplifies deployment, and decreases costs through unified MCT and Holter monitoring technology.

ECG Devices Segment Dominates the Market

ECG devices dominate the ambulatory cardiac monitoring devices market because of their user-friendly design. Also, it effortlessly connects with mobile technologies and enables patients to track their heart activity from anywhere, thus augmenting compliance and engagement. Modern ECG devices will easily integrate with smartphones and tablets, making it easier to monitor heart health for a patient and share the data provided with their healthcare providers; thus, these features support the dominance of ECG devices in the market. At the same time, cardiac telemetry is the fastest-growing segment. The growing FDA clearance for new cardiac telemetry products shows a high demand, which provides tremendous market opportunities.

For instance, in November 2024, SmartCardia SA received FDA clearance for the company's 7-lead live ECG monitoring patch intended for Mobile Outpatient Cardiac Telemetry (OCT/MCT). This waterproof and cable-free patch allows continuous monitoring for up to 14 days. The added feature of remote live ECG monitoring alerts clinicians instantaneously about clinically significant arrhythmias. Cardiac telemetry systems provide continuous real-time monitoring, thus helping patients and allowing early intervention in heart conditions, which is necessary for treating heart conditions. Therefore, this dual trend of developing ECG devices and increased adoption of cardiac telemetry underlines the dynamic evolution of the ambulatory cardiac monitoring market.

North America to Hold Major Market Share

North America has a significant share of the ambulatory cardiac monitoring devices market. The rising heart disease cases are attributed to the market's growth in the region. The Heart Disease and Stroke Statistics: the American Heart Association (AHA) report highlights the alarming statistics. The data estimated that every 34 seconds, someone dies from CVD, and every day in the U.S., 2,552 deaths are reported from CVD. Such facts point to a critical requirement for effective cardiac monitoring solutions. The North American market is increasing due to the availability of treatment solutions on a broad spectrum of distribution channels, the intense presence of key market players, and higher awareness about heart diseases. In September 2024, InfoBionic.Ai, the leading digital health company, launched its ambulatory ECG monitoring system, MoMe.net, in Epic Showroom's Connection Hub. Such innovations, along with the growing incidence of CVD, help to expand the market in this region further and make North America the market leader in the world's ambulatory cardiac monitoring devices market. Additionally, strong reimbursement policies like Medicare spur the growth of the market. The awareness about heart health created by private and governmental organizations increases demand in the market.

Future Market Scenario (2025-2032F)

Ambulatory cardiac monitoring devices hold a very promising future with inventions like minimally invasive techniques and more advanced devices like implantable loop recorders and mobile cardiac telemetry. Favorable reimbursement policies, increased expenditure on health care, and raising awareness of heart health shall make the market highly attractive to manufacturers in this emerging landscape.

In November 2024, Monitra Healthcare Pvt. Ltd. received a U.S. patent for its advanced wireless cardiac monitoring technology. This patch-based system enhances patient compliance and diagnostic accuracy by automatically detecting its orientation and selecting electrode pairs for optimal signal quality, transmitting real-time physiological data wirelessly for analysis. Such innovations create significant market opportunities.

Companies are also upgrading their devices with AI integration that strengthens portfolios and expands the market. In July 2024, Octagos Health, Inc. raised more than USD 43 million to advance AI-driven cardiac device monitoring. Their Atlas AI platform offers continuous monitoring, accurate event detection, EHR integration, and customizable reports that improve decision-making and patient outcomes in cardiology practices.

Key Players Landscape and Outlook

Market players are strengthening their position by acquiring more regulatory approvals and launching new products. These strategies serve to help them expand their market share very effectively. In September 2024, iRhythm Technologies, Inc. received regulatory approval from Japan's PMDA for the Zio 14-day continuous ECG monitoring system. With this approval, iRhythm can obtain reimbursement from the Japanese Ministry of Health, Labour, and Welfare, thereby increasing its market presence and expanding access to its innovative ECG monitoring technology in Japan.

In June 2024, Koninklijke Philips N.V. launched Cardiac Workstation, a new platform for enhancing cardiology patient care and accelerating clinical decision-making in Europe, the Middle East, and Africa. This is a point-of-care and remote analysis of ECG data by advanced algorithms. This innovation further strengthens Philips' market presence, indicating a commitment to advanced healthcare solutions.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Device Type
      • 4.2.1.1. Electrocardiography (ECG) Devices
        • 4.2.1.1.1. Holter Monitors
        • 4.2.1.1.2. Mobile Cardiac Telemetry (MCT)
        • 4.2.1.1.3. Event Monitors
        • 4.2.1.1.4. Implantable Loop Recorders (ILR)
      • 4.2.1.2. Wearable Devices
      • 4.2.1.3. Other Devices
    • 4.2.2. By End-user
      • 4.2.2.1. Hospitals and Clinics
      • 4.2.2.2. Ambulatory Care Centers
      • 4.2.2.3. Home Healthcare
    • 4.2.3. By Region
      • 4.2.3.1. North America
      • 4.2.3.2. Europe
      • 4.2.3.3. Asia-Pacific
      • 4.2.3.4. South America
      • 4.2.3.5. Middle East and Africa
    • 4.2.4. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 4.3. Market Map Analysis, 2024
    • 4.3.1. By Device Type
    • 4.3.2. By End-user
    • 4.3.3. By Region

5. North America Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Device Type
      • 5.2.1.1. Electrocardiography (ECG) Devices
        • 5.2.1.1.1. Holter Monitors
        • 5.2.1.1.2. Mobile Cardiac Telemetry (MCT)
        • 5.2.1.1.3. Event Monitors
        • 5.2.1.1.4. Implantable Loop Recorders (ILR)
      • 5.2.1.2. Wearable Devices
      • 5.2.1.3. Other Devices
    • 5.2.2. By End-user
      • 5.2.2.1. Hospitals and Clinics
      • 5.2.2.2. Ambulatory Care Centers
      • 5.2.2.3. Home Healthcare
    • 5.2.3. By Country Share
      • 5.2.3.1. United States
      • 5.2.3.2. Canada
      • 5.2.3.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
        • 5.3.1.1.2. By Volume
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Device Type
          • 5.3.1.2.1.1. Electrocardiography (ECG) Devices
          • 5.3.1.2.1.1.1. Holter Monitors
          • 5.3.1.2.1.1.2. Mobile Cardiac Telemetry (MCT)
          • 5.3.1.2.1.1.3. Event Monitors
          • 5.3.1.2.1.1.4. Implantable Loop Recorders (ILR)
          • 5.3.1.2.1.2. Wearable Devices
          • 5.3.1.2.1.3. Other Devices
        • 5.3.1.2.2. By End-user
          • 5.3.1.2.2.1. Hospitals and Clinics
          • 5.3.1.2.2.2. Ambulatory Care Centers
          • 5.3.1.2.2.3. Home Healthcare
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Turkey
  • 6.9. Poland

7. Asia-Pacific Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Ambulatory Cardiac Monitoring Devices Market Outlook, 2018-2032F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Regulatory Approvals

19. Case Studies

20. Competitive Landscape

  • 20.1. Competition Matrix of Top 5 Market Leaders
  • 20.2. SWOT Analysis for Top 5 Players
  • 20.3. Key Players Landscape for Top 10 Market Players
    • 20.3.1. Medtronic plc
      • 20.3.1.1. Company Details
      • 20.3.1.2. Key Management Personnel
      • 20.3.1.3. Products and Services
      • 20.3.1.4. Financials (As Reported)
      • 20.3.1.5. Key Market Focus and Geographical Presence
      • 20.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 20.3.2. Boston Scientific Corporation
    • 20.3.3. Koninklijke Philips N.V.
    • 20.3.4. GE HealthCare Technologies Inc.
    • 20.3.5. Medicomp Systems, Inc.
    • 20.3.6. Biotronik SE & Co KG
    • 20.3.7. iRhythm Technologies, Inc.
    • 20.3.8. Hill-Rom Holdings, Inc.
    • 20.3.9. Schiller AG
    • 20.3.10. Nihon Kohden America, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

21. Strategic Recommendations

22. About Us and Disclaimer